Exploring Health Economic Evaluation Methods for Disease Screening
- VernacularTitle:疾病筛查的卫生经济学评价方法探讨
- Author:
Dunming XIAO
1
,
2
;
Shiqin ZHANG
;
Dai LIAN
;
Shanyan ZHOU
;
Yingyao CHEN
Author Information
1. 复旦大学公共卫生学院 上海 200032
2. 国家卫生健康委员会卫生技术评估重点实验室(复旦大学) 上海 200032
- Keywords:
screening;
decision analysis;
modern epidemiology;
health statistics;
health economics
- From:
Chinese Health Economics
2024;43(8):5-10
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the health economic evaluation methods of disease screening,providing insights for scholars conducting related research.Methods:By integrating relevant content from modem epidemiology,health statistics,and health economics,it investigates the differences in conducting health economic evaluations of disease screening using authenticity indicators(sensitivity,specificity)and predictive value indicators(positive predictive value,negative predictive value),and combines empirical studies with cases from the literature.Results:Authenticity indicators(sensitivity,specificity)are intrinsic measures of diagnostic tests,unaffected by the disease prevalence in the sample population,making them more suitable for conducting health economic evaluations of disease screening.Moreover,authenticity indicators are easy to obtain,and the model calculations are straightforward and convenient.Case study results demonstrate that compared to risk score screening,the Incremental Cost-Effectiveness Ratio(ICER)of fasting plasma glucose(FPG)testing for type 2 diabetes is 626,indicating that for every additional diabetic patient identified through risk score screening,an extra 626 yuan is spent.Conclusion:It is recommended to use authenticity indicators for conducting health economic evaluations of disease screening,standardize the path methods for model selection,and continuously improve the evidence quality of health economic evaluations of disease screening in China.
